✨
AI Summary
- Adaptimmune discusses TCR T-cell therapy and the TECELRA trial.
- TECELRA trial led to FDA approval for solid tumors.
- Focus on improving TCR T-cell persistence and efficacy.
Guests on This Episode
DW
Dennis Williams
1 podcast appearance